Auric, As I've stated numerous times, you lack the details. Now the proof is even more obvious.
Regarding CEL-SCI, a company I've followed since 1985 (I started at a very young age), what's your question? Is there something you'd like me to help you with? CEL-SCI (symbol: HIV) is a company developing vaccines for HIV, Malaria, Tuberculosis, Herpes, etc. They also have a drug, Multikine, that reduces cancerous tumors VERY aggressively and may cause an immune response that prevents the cancer from reoccuring. IMO, this company is likely to make history in the next few years.
Being a Biotech company, HIV is very slow going and must constantly deal with the FDA, etc. It is likely to be at least 2 or 3 years before they have an approved drug to market. With Advanced Engine Technology (AENG), the company under occasional discussion here on its own BB, this isn't the case. There's no FDA to deal with. Yes, there is the EPA, but that's a walk in the park compared to the FDA and drug regulation.
To be honest with you, I'm not real happy with HIV at the moment. The CEO allowed some warrants to expire, in which I was heavily invested, because he felt they were being used by the shorts to protect against a strong upward move. I took a 100% loss. It wasn't pleasant.
Beyond my own painful financial experience with the company, I still believe the drugs are miraculous, so I can't very well trash the company now can I? I'm so minimally invested in HIV at this time, it's probably my smallest position. But I still know it well, so I'll be happy to answer your questions for you.
IMO and in the opinion of numerous others (I'm sure), let's leave the discussion on this BB to AENG or at least some remote relation to AENG. I'll be happy to take CEL-SCI up with you via e-mail. My e-mail address is available to you and other SI subscribers.
If you're trying to relate TRAV to CEL-SCI, you're at least a light-year off base. You're soooo good with the details. NOT! But keep trying............the comedy amuses many of us.
Best of Luck, Greg
|
